Last $11.02 USD
Change Today +0.07 / 0.64%
Volume 1.4M
NKTR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert B. Chess

AgeTotal Calculated CompensationThis person is connected to 140 board members in 6 different organizations across 6 different industries.

See Board Relationships
57$414,180

Background*

Mr. Robert B. Chess, also known as Rob, served as Chief Executive Officer of OPX Biotechnologies, Inc. Mr. Chess served as the President and Chief Executive Officer of Nektar Therapeutics from March 17, 2006 to January 15, 2007 and served as its Interim President and Acting Chief Executive Officer from March 17, 2006 to January 15, 2007. Mr. Chess served as an Interim President and Chief Executive Officer of Nektar Therapeutics, from 1992 to 2000. He served as Co-Chief ...

Read Full Background

Corporate Headquarters*

455 Mission Bay Boulevard South
San Francisco, California 94158

United States

Phone: 415-482-5300
Fax: 415-339-5300

Board Members Memberships*

Director
Director
Director
Chairman
Director
1992-Present
Chairman
2000-2006
Former Director
2004-Present
Independent Director and Member of Nominating & Corporate Governance Committee
2007-2009
Former Director

Education*

MBA
Harvard Business School
BSE
California Institute of Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$113,000
Total Calculated Compensation$414,180
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NKTR:US $11.02 USD +0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Peter William Grant Chief Executive Officer and Executive Director
SkyePharma plc
567.0K GBP
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEKTAR THERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.